Biliary Stents Market Size, Share, Growth, and Industry Analysis, By Type (Metal Stents, Plastic Stents), By Application (Hospitals, ASC, Others), Regional Insights and Forecast to 2035

Biliary Stents Market Overview

Global Biliary Stents Market size is estimated at USD 232.81 million in 2026 and is expected to reach USD 316.05 million by 2035 at a 3.4% CAGR.

The Biliary Stents Market is expanding due to increasing prevalence of biliary disorders, rising demand for minimally invasive procedures, and growing adoption of endoscopic treatment methods for bile duct obstruction. Biliary stents are widely used to restore bile flow in patients suffering from conditions such as malignant and benign biliary strictures, pancreatic diseases, and other hepatobiliary disorders. Metal Stents and Plastic Stents are the primary product categories, with hospitals, ambulatory surgical centers, and other digital healthcare facilities adopting these devices based on patient requirements, treatment complexity, and procedural preferences.

In the United States, the Biliary Stents Market is developing through increasing adoption of advanced endoscopic procedures, expanding healthcare infrastructure, and growing demand for minimally invasive gastrointestinal interventions. Hospitals remain the major users due to their ability to perform complex procedures and provide specialized care. Manufacturers are focusing on improving stent design, enhancing placement accuracy, and developing solutions that provide better patient outcomes. The rising burden of biliary diseases and increasing preference for advanced medical devices are supporting continued adoption across healthcare facilities.

Key Findings

• Market Driver: Increasing demand for minimally invasive biliary procedures is supporting market growth, with Hospitals accounting for approximately 60% of biliary stent application demand due to advanced treatment capabilities.
• Major Market Restraint: High procedure complexity and risks associated with stent placement remain challenges, with approximately 2 major factors including complications and device selection affecting adoption.
• Emerging Trends: Advanced stent technologies are gaining attention, with Metal Stents representing approximately 55% of market demand due to improved durability and longer placement benefits.
• Regional Leadership: North America leads the Biliary Stents Market with approximately 40% share, supported by advanced healthcare infrastructure, endoscopic procedure adoption, and strong medical device availability.
• Competitive Landscape: Companies are focusing on product innovation and advanced stent designs, with leading manufacturers expanding solutions across Hospitals, ASC, and specialty healthcare facilities.
• Market Segmentation: Metal Stents dominate product demand with approximately 55% share, while Hospitals represent the leading application segment with approximately 60% market adoption.
• Recent Development: Manufacturers are developing improved biliary stent solutions with enhanced placement technology and patient safety features, supporting approximately 3 major areas of innovation including design, material, and delivery systems.

Latest Trends

The Biliary Stents Market is witnessing increasing adoption of advanced stent technologies designed to improve treatment outcomes, reduce complications, and enhance procedural efficiency. Metal Stents are gaining importance due to their durability, larger expansion capability, and suitability for complex biliary conditions. Approximately 55% of market demand is associated with Metal Stents, supported by their increasing use in malignant biliary obstruction procedures. Healthcare providers are focusing on devices that provide improved drainage performance, longer placement duration, and better patient comfort.

Another significant trend is the development of minimally invasive treatment approaches and improved endoscopic techniques. Hospitals and ambulatory surgical centers are increasingly adopting advanced biliary intervention procedures to reduce recovery time and improve patient management. Approximately 3 key factors, including stent placement accuracy, material performance, and procedural efficiency, are influencing product development strategies. Manufacturers are investing in innovative designs, improved delivery systems, and specialized stent solutions to address evolving clinical requirements.

Market Dynamics

Driver

"Growing adoption of minimally invasive biliary procedures."

Increasing demand for minimally invasive treatment options is driving growth in the Biliary Stents Market as healthcare providers increasingly prefer endoscopic procedures for managing bile duct obstruction and related disorders. Biliary stents provide effective drainage solutions and support treatment for malignant and benign biliary conditions. Hospitals represent approximately 60% of application demand due to their advanced diagnostic capabilities, specialized medical teams, and availability of endoscopic treatment facilities.

The rising prevalence of hepatobiliary diseases and increasing adoption of advanced gastrointestinal procedures are further supporting market expansion. Metal Stents account for approximately 55% of product demand due to their durability, longer placement benefits, and suitability for complex biliary interventions. Manufacturers are focusing on improved stent designs, enhanced delivery systems, and better patient outcomes to address increasing clinical requirements.

Restraint

"Complex procedures and potential complications limit adoption."

The Biliary Stents Market faces challenges due to procedural complexity, risk of complications, and the need for specialized medical expertise. Stent placement requires accurate diagnosis, proper device selection, and experienced healthcare professionals to achieve effective outcomes. Approximately 2 major factors, including post-procedure complications and device compatibility, influence treatment decisions.

The cost associated with advanced biliary stent procedures and specialized equipment can also affect adoption, particularly in developing healthcare markets. Healthcare providers must evaluate patient conditions, stent performance, and long-term treatment requirements before selecting suitable devices. These factors can increase decision-making complexity and influence market growth.

Opportunity

"Advancements in stent technology create growth opportunities."

Technological advancements in biliary stent design are creating new opportunities for market participants. Manufacturers are developing improved Metal Stents and Plastic Stents with enhanced flexibility, placement accuracy, and patient safety features. Increasing demand for minimally invasive procedures and personalized treatment approaches is encouraging companies to invest in innovative medical device solutions.

Growing healthcare infrastructure development and increasing access to advanced gastrointestinal procedures are also creating opportunities across emerging markets. Hospitals and ambulatory surgical centers are expanding their capabilities, supporting greater adoption of biliary stent technologies. Approximately 3 major innovation areas, including materials, delivery systems, and stent designs, are shaping future product development strategies.

Challenge

"Maintaining safety and performance standards remains challenging."

Manufacturers face challenges in developing biliary stents that provide reliable performance while minimizing complications. Advanced applications require devices with improved biocompatibility, accurate placement, and long-term effectiveness. Maintaining consistent product quality and meeting regulatory requirements remain important priorities for companies operating in this market.

Another challenge is balancing innovation with affordability. Healthcare providers require effective solutions that deliver improved patient outcomes while managing procedural costs. Companies must continue investing in research, manufacturing improvements, and quality control systems to develop advanced biliary stents that meet evolving clinical expectations.

Biliary Stents Market Segmentation

By Types

Metal Stents: Metal Stents represent approximately 55% of the Biliary Stents Market demand and remain the leading product segment due to their durability, larger expansion capability, and suitability for complex biliary obstruction procedures. These stents are widely used in cases requiring longer-term drainage support, particularly for malignant biliary conditions where improved patency and reduced replacement frequency are important clinical considerations. The Metal Stents segment continues to benefit from technological improvements in stent materials, flexibility, and delivery systems. Approximately 3 major performance factors, including expansion capability, placement accuracy, and long-term stability, influence adoption among healthcare providers. Manufacturers are focusing on developing advanced metal-based solutions that improve patient outcomes while supporting minimally invasive treatment approaches.

Plastic Stents: Plastic Stents account for approximately 45% of market demand and remain an important product category due to their affordability, ease of placement, and suitability for temporary biliary drainage procedures. These stents are commonly used in benign biliary conditions and situations where short-term drainage support is required. The Plastic Stents segment continues to maintain demand across hospitals and ambulatory surgical centers due to their flexibility and cost advantages. Approximately 2 major clinical considerations, including treatment duration and patient condition, influence plastic stent selection. Manufacturers are improving plastic stent designs by focusing on better flow characteristics, reduced complications, and enhanced procedural performance.

By Applications

Hospitals: Hospitals represent approximately 60% of Biliary Stents Market demand and remain the leading application segment due to their advanced medical infrastructure, specialized gastrointestinal departments, and availability of endoscopic treatment facilities. Hospitals perform a significant number of complex biliary procedures requiring reliable stent solutions for effective bile drainage and patient management. The hospital segment benefits from increasing adoption of minimally invasive procedures and rising demand for advanced gastrointestinal interventions. Approximately 3 major capabilities, including diagnostic services, surgical expertise, and specialized equipment availability, support hospital-based adoption of biliary stents. Manufacturers are strengthening partnerships with healthcare institutions to improve product accessibility and clinical adoption.

ASC: Ambulatory Surgical Centers account for approximately 25% of Biliary Stents Market demand as healthcare systems increasingly adopt outpatient procedures and cost-efficient treatment models. ASCs provide faster patient recovery, reduced hospital stays, and specialized procedural environments for selected biliary interventions. The ASC segment is gaining importance due to improvements in endoscopic technologies and increasing preference for minimally invasive treatments. Approximately 2 key factors, including procedure efficiency and reduced treatment costs, influence adoption within ambulatory surgical facilities. Manufacturers are developing easy-to-use stent delivery systems to support growing demand from outpatient healthcare settings.

Others: Other applications contribute approximately 15% of market demand and include specialty clinics, diagnostic centers, and additional healthcare facilities involved in biliary treatment procedures. These facilities support market expansion by increasing access to specialized gastrointestinal care outside traditional hospital environments. The Others segment is supported by improving healthcare infrastructure and rising demand for advanced diagnostic and therapeutic procedures. Approximately 3 factors, including healthcare accessibility, specialist availability, and procedural advancements, influence adoption across these facilities. Companies are expanding distribution networks to improve availability of biliary stent products in diverse healthcare settings.

Regional Outlook

North America

North America leads the Biliary Stents Market with approximately 40% share, supported by advanced healthcare infrastructure, strong adoption of minimally invasive gastrointestinal procedures, and increasing availability of advanced endoscopic technologies. The United States represents the largest contributor due to rising demand for biliary interventions, well-established hospitals, and increasing investment in specialized healthcare services. The region benefits from strong presence of medical device manufacturers and advanced treatment facilities.

The regional market is further supported by increasing cases of biliary disorders and growing preference for effective drainage solutions. Hospitals remain the primary users, accounting for approximately 60% of application demand due to their specialized capabilities and access to advanced medical equipment. Companies are focusing on improving stent designs, enhancing procedural efficiency, and developing solutions that support better patient outcomes across North American healthcare facilities.

Europe

Europe represents approximately 30% of the Biliary Stents Market, supported by developed healthcare systems, increasing adoption of minimally invasive procedures, and growing demand for advanced gastrointestinal treatment solutions. Countries including Germany, France, the United Kingdom, and Italy contribute significantly due to strong hospital infrastructure and increasing investment in medical technologies.

The regional market is influenced by rising awareness of advanced treatment options and increasing demand for efficient biliary drainage procedures. Approximately 3 major factors, including healthcare modernization, increasing patient access, and adoption of advanced medical devices, are supporting market expansion. Manufacturers are strengthening partnerships with hospitals and healthcare providers to improve product availability across Europe.

Asia-Pacific

Asia-Pacific accounts for approximately 20% of the Biliary Stents Market and is emerging as a growth-focused region due to increasing healthcare investments, expanding hospital infrastructure, and rising adoption of advanced medical procedures. Countries including China, Japan, India, and South Korea are contributing to regional demand through improving access to gastrointestinal treatments.

The region is benefiting from increasing healthcare expenditure, growing patient populations, and expanding availability of minimally invasive procedures. Approximately 3 key factors, including rising medical infrastructure development, increasing specialist availability, and improving healthcare accessibility, are supporting adoption. Companies are focusing on affordable solutions and wider distribution networks to capture opportunities across developing markets.

Middle East and Africa

Middle East and Africa account for approximately 7% of the Biliary Stents Market, supported by gradual healthcare infrastructure development, increasing investment in medical facilities, and rising awareness of advanced treatment procedures. Major urban healthcare centers are adopting improved endoscopic technologies to manage biliary conditions more effectively.

The region continues developing through healthcare modernization programs and increasing access to specialized medical services. Approximately 2 major factors, including rising healthcare investment and growing demand for minimally invasive treatments, are supporting market opportunities. Companies are expanding distribution partnerships to improve availability of biliary stent products across regional healthcare facilities.

Rest of World

Rest of World represents approximately 3% of the Biliary Stents Market, including Latin America and other emerging economies. Growth is supported by improving healthcare infrastructure, increasing adoption of gastrointestinal procedures, and rising demand for cost-effective medical treatment solutions.

Manufacturers are targeting these markets through expanded distribution networks, strategic partnerships, and affordable product offerings. Approximately 3 areas, including specialty healthcare facilities, diagnostic centers, and developing hospital networks, are creating additional opportunities for biliary stent adoption in emerging regions.

List of Top Biliary Stents Companies

• Abbott Vascular
• Boston Scientific
• Cook Medical
• C. R. Bard
• Medtronic
• Taewoong Medical

Top 2 Companies with Highest Market Share

• Boston Scientific: Boston Scientific maintains a strong position in the Biliary Stents Market through its advanced endoscopy portfolio and focus on innovative biliary intervention solutions. The company supports hospitals and healthcare providers with specialized stent technologies designed for improved procedural performance. Approximately 3 major areas, including product innovation, clinical support, and global healthcare distribution, influence its competitive position.
• Medtronic: Medtronic competes in the Biliary Stents Market through its broad medical technology expertise and focus on advanced minimally invasive treatment solutions. The company continues developing healthcare products that support gastrointestinal procedures and improved patient management. Approximately 3 key factors, including technology development, healthcare partnerships, and global presence, contribute to its market strength.

Investment Analysis and Opportunities

Investment opportunities in the Biliary Stents Market are increasing due to rising demand for minimally invasive gastrointestinal procedures, advanced endoscopic technologies, and improved patient management solutions. Companies are focusing on developing innovative Metal Stents and Plastic Stents with enhanced durability, improved placement accuracy, and better clinical performance. Hospitals account for approximately 60% of application demand, creating strong opportunities for manufacturers developing products designed for complex biliary procedures.

Healthcare modernization and increasing access to advanced medical treatments are creating additional investment opportunities across emerging markets. Companies are investing in research, manufacturing improvements, and distribution expansion to strengthen market presence. Approximately 3 major investment areas, including stent technology development, healthcare partnerships, and procedural innovation, are influencing future growth strategies within the Biliary Stents Market.

New Product Development

New product development in the Biliary Stents Market is focused on improving stent performance, reducing complications, and enhancing procedural efficiency. Manufacturers are developing advanced Metal Stents with improved expansion capability, flexibility, and placement control to support complex biliary interventions. Approximately 55% of market demand is associated with Metal Stents, encouraging companies to invest in advanced material technologies and improved delivery systems.

Companies are also developing enhanced Plastic Stents designed for temporary drainage procedures and improved patient outcomes. Product innovation is increasingly focused on biocompatibility, ease of deployment, and reduced procedure-related risks. Approximately 3 major development areas, including material improvement, delivery technology, and stent design optimization, are shaping future product strategies across healthcare applications.

Five Recent Developments

• January 2025: Medical device manufacturers increased focus on advanced biliary stent designs with improved placement systems and enhanced patient safety features to support minimally invasive procedures.
• April 2025: Companies expanded research activities for next-generation Metal Stents, focusing on improved durability, flexibility, and long-term performance in complex biliary conditions.
• July 2025: Healthcare technology providers strengthened partnerships with hospitals and specialty centers to improve access to advanced biliary intervention solutions.
• October 2025: Manufacturers introduced improved delivery systems designed to enhance procedural accuracy and reduce complexity during biliary stent placement procedures.
• February 2026: Companies increased investment in innovative stent materials and customized solutions to support growing demand for minimally invasive gastrointestinal treatments.

Report Coverage

The Biliary Stents Market report covers Metal Stents and Plastic Stents product categories along with applications including Hospitals, ASC, and Others. The analysis evaluates market trends, product developments, competitive strategies, technological advancements, and factors influencing biliary stent adoption across healthcare facilities.

The report provides regional analysis across North America, Europe, Asia-Pacific, Middle East and Africa, and Rest of World. It examines market opportunities, investment trends, product innovation activities, and competitive positioning of key companies including Abbott Vascular, Boston Scientific, Cook Medical, C. R. Bard, Medtronic, and Taewoong Medical.